Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer, compared to other publicly available fusion detection algorithms. The tool, detailed in an article published in The Journal of Molecular Diagnostics, enables a higher diagnostic yield from low-coverage, low-cost sequencing.